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Major advances in the  management  of  the  preterm  low  birth  
weight infants like  surfactant, ventilator care, Total Parental Nutrition, 
central lines, Kangaroo Mother Care, breast milk banking, early feed  
advancement policy, better asepsis protocols, Antenatal steroids and 
developmentally oriented supportive care have failed to produce 
uniformly good outcomes. Sepsis is the major contributor to the 
mortality. Despite the usage of highly  potent  antimicrobials,  emergence  
of  resistant organisms  plague  the  various  newborn  care  facilities. 
This  has  led  to  a search  for alternative  therapies  to  combat  sepsis  
like  IVIG and  GM-CSF. These  have been proven  to  have  doubtful  
efficacy  in  recent  studies. Against  this  background  BCG  vaccine  has  
generated  great interest  in  the western  world  recently  for  its  non-
specific immune modulatory  effects   in  various  diseases  like  Allergy, 
Cancer, Chronic  diseases  like  Multiple  Sclerosis  and  Diabetes. 
Historically,  since  its  introduction  it  had  reduced  infant  mortality  
rates  nonspecifically  in  certain  studies  in the  1940’s  and 1950’s. This  
went  unrecognized till  now  and  interest  has  been  rekindled  in   this  
age  old  vaccine. 
Recently 2  RCT’s  in  West Africa  had  found  that  early BCG  
vaccine  in  low 
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birth  weight   newborns reduced  neonatal  mortality  significantly  by  
decreasing the incidence of  sepsis  and  pneumonia  in  these neonates. 
Based  on  these  findings  there  is  currently  a  trial   going  on  in  
Netherlands to study  the effect  of  BCG  on  infant  morbidity. Another 
study  is  going  on  in Australia to determine  if  it  reduces  allergy  and  
asthma. A recent  large  retrospective  cohort  study  done  in Australia  
studying  a cohort  distributed  in  many  countries  concluded  that  BCG  
reduced  acute  lower  respiratory  tract  infections  significantly. 
Molecular studies also support  BCG vaccines’ ability  to  enhance  
immunity  (both  innate  and  adaptive)  by  novel  mechanisms. 
Administration of BCG is delayed for LBW infants in our setting which 
is similar to Guinea-Bissau. Hence a similar trial to study the effect of 
early BCG is justified. 
This  low  cost  intervention  if  found  to  be  beneficial  as  certain  
studies  suggest could  save a lot  of  lives  and  will  also  have  monetary  
benefits  in a resource limited setting. 
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REVIEW OF LITERATURE 
Bacterial sepsis is a major contributor to neonatal mortality and 
morbidity. 40% of neonatal  deaths in India is attributed  to sepsis and  
sepsis related causes1,2.Approximately 20% incidence  occurs in various  
newborn  care  facilities according  to  Neonatal Perinatal  
Database(2003).Neonatal  Sepsis  incidence  in  the  community is 30 per 
thousand population3. 
The signs and symptoms of  sepsis   in  a neonate are irritability, 
lethargy, respiratory distress, cyanosis, acidosis, vomiting, poor feeding, 
unexplained jaundice, bleeding  manifestations, changes in body 
temperature ,hypoglycemia or hyperglycemia, pulmonary hypertension, 
hypotonia, or seizure 4. The clinical status of neonates can worsen quickly 
and lead to rapid deterioration. These unique features dictate that the 
definition of neonatal sepsis remains vague and flexible to physician’s 
interpretation. Neonatal Sepsis includes septicemia, meningitis, 
pneumonia, arthritis, osteomyelitis and urinary tract infections. 
Superficial infections like conjunctivitis and oral thrush are not usually 
included under neonatal sepsis. 
 
The  scenario and  prevalence  in India 
 
The  largest  perinatal  and  Neonatal  Data base  in India 2003 
states  that neonatal  sepsis  occurs  with  a  frequency  of  30 per  
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thousand  live  births. Eighteen  NICU units  in  India  which  contributed  
to  the  Database  state that sepsis is one of  the  leading  causes of  
neonatal  mortality3. The gram negative  bacteria  are  a  leading  cause  
of  sepsis  in  both  inborn  and out born  newborn  care  units. 
Staphylococcus Aureus sepsis  occurred  in  13.6% cases  & Klebsiella  
accounted  for  32.5%  of  cases  in  Inborn  units. In  out born  neonatal 
units  pseudomonas  was  also  isolated  and  it  accounted  for  10-12%  
of  cases and Klebsiella occurred  in  27%  of  cases. 
The major categories of  neonatal  sepsis 
 
Sepsis in  the  newborn  period    is  divided  in  to  two  types. It  is  
based  on  the  timing  of  occurrence  of  initial  symptoms  of  infection. 
Symptoms  occurring  within  the  first  seventy  two  hours  of  life  
defines  early  onset  sepsis. The respiratory symptoms predominate in 
early onset sepsis. The organisms are acquired from  the  mothers  
reproductive  tract and certain maternal factors like PPROM and 
Chorioamniotis increase the risk.  Neonatal characteristics like birth 
weight  less  than  2.5 kg or  gestational  age  less  than  37  weeks, 
meconium staining  of  amniotic  fluid and  Apgar  less than four  at  one  
minute causes an  increase in sepsis  incidence5. 
 
Clinical symptoms occurring beyond  seventy  two  hours of life is  
late  onset   sepsis (LOS). It  is  usually acquired  from  the  hospital or 
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community . Prematurity, LBW, Ventilator  therapy, peripheral& central  
lines, procedures  related  to NICU  care are  certain  conditions  that  
predispose  the  neonate  to  LOS. It  usually manifests  as  septicemia 
.Rarely  CNS  infection can  occur6,7.  
The immunologically vulnerable preterm  Neonate  : 
 
 
Newborn period  is a very vulnerable period  for sepsis. This is 
mainly due to defects and immaturity of their immune system. Both 
innate and adaptive immunity show immaturity. These defects are further 
amplified in the preterm and low birth weight infants. The compromised 
nature of immune system in a developing preterm and low birth weight 
neonate’s host defense system allows for bacterial dissemination to 
extravascular and intravascular sites, including the meninges, lungs and 
bones. 
The innate, immune response is nonspecific and not influenced by 
prior antigen interaction. Various physical (e.g.cilia,skin8, mucus) and 
biochemical barriers(e.g., lysozyme, gastric acid, surfactant proteins) as 
well as phagocytic cells (e.g. macrophages and granulocytes) and the 
plasma factors (e.g., acute-phase proteins ,the complement system, the 
coagulation cascade, and pattern recognition receptor’s like , NOD , 
Toll)comprise innate immune responses. 
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The acquired or adaptive immune response is specific. It is 
comprised  of a memory, or an anamnestic response to antigen re-
exposure. Acquired immune responses include cell  mediated immunity, 
humoral immunity involving  Immunoglobulin production by B 
lymphocytes and associated factors like Natural killer [NK] cells, 
cytokines, and interleukins. 
The vulnerability of the low birth weight and low gestational  age 
premature infants. 
The  epidermis of  preterm, low  birth  weight  newborn  is  thin. 
The stratumcorneum is also  very thin8.Procedures like  central and  
peripheral  intravenous  catheter  insertion adds  to the  susceptibility  of  
the  thin skin  to microbial  invasion. The  bronchial  mucosa  is  
vulnerable  to  infection  due to  less quantity  of protective  mucinous  
glycoprotein  in the  respiratory  secretions10.This vulnerability to  
infection  is  further  exacerbated  during  invasive  mechanical  
ventilation. The  ability  to  cough effectively is  also  impaired  in the 
low birth  weight  preterm newborns. The  gut is the next  most  common  
site  of  entry  of  microbes in birth  weight  newborn  less  than  thirty 
two  weeks  gestation  age. Adherence  of  microbes  to  gut  mucosa  
occurs  easily because ofl ow intestinal  motility9.The  stomach  
hydrochloric  acid  production  is  low and  the  stomach  pH is  high. The  
intestinal IgA quantity  and the secretory fraction  of  this  
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immunoglobulin is especially low  in  the premature  newborn. The  
integument  and  the  gut mucosa   produce  low  quantity  of  Defense  in 
a polypeptide  molecule. This  compound  neutralizes  bacteria  by  
affecting  DNA transcription  and  increasing the   production  of  
immunologically  active  molecules  and  cytokines. This   compound also  
acts  as  chemo attractant to  polymorphs  and  macrophages. They  
modify  the  function  of  the  effect or limb  of  the  immune  system . 
Lipopolysaccharide  and  endotoxin  production  by  bacteria  is  also  
inhibited  by  defensins. The  immune  response  of  various  antigen  
presenting  cells  is  also  influenced  and  modified  by Defensins11,12,13. 
The innate form of immune response in preterm  population 
Macrophages and  the  antigen  presenting  cell have  less ability  to  
produce  colony  stimulating factor and   have  impairment  in  
identification of  microbes  by  pattern  recognizing  molecules11.These  
cells also  produce  less  proinflammatory  and  immune protective   
polypeptide  molecules called cytokines. The  cytokines  are  necessary  
to  activate  the  innate  immune  system12,13.The  polymorphs and  
monocytes  have  less  capacity  for  phagocytosis and  less  
mobility14.This  causes reduced  numbers  of  these  cells  at  the  sites  of  
infection15.The  CD8 cell  number  is  also  less in  preterm infants and  
their  function  is  also  reduced. The  killer  cells  of  the  lymphocytic  
system - the  NK cells  are  reduced  in  number16.Anti body independent 
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cytotoxicity and antibody dependent killing  capacity  of  the  cells  is  
less. The complement cascade complex system is also defective16. 
Specific  immunity  is  also  affected by  reduced  effectiveness  of  
the  complement  system17.These  reduce  the  quantity  of  immunogen 
necessary  for  adequate  production  of  antibodies. The  preterm 
newborn  also  has  less capacity  to  secrete gamma  interferon. This  
antiviral  substance  is  secreted  by  cells which  have  been  invaded  by  
viruses. The  macrophages  then  recognize  those  cells  with  viral  load  




Adaptiv ehumoral and adaptive cell mediated immunity in preterm 
neonates. 
 
Acquired  specific  cell  mediated  and  humoralmediated  immune 
responses in  the preterm  infant   is  both  immature  and  also  attenuated  
when  compared  with  a term  newborn. Though  the  quantity  of  thymic  
lymphocytes  is  more  in  preterm  neonate  when compared  to  an older  
infant,  the  quality  of  immune  responses  is  both  different  and  
deficient18.TheThymic  helper cell type 1(Th1) response in  preterm is 
defective. The  Th1  response  is  necessary  for  enhancement  of  
cytotoxic  function  of  lymphocytes  and  also  production  of gamma  
interferon. This  form  of  cell  mediated  immunity  is  necessary  for  
destruction  of  intracellular  pathogens  in  particular19.The Thymic  
helper cell type 2 (Th2)  polarized  response   is  deficient in comparison  
to  an  older  term  infant. The thymic  lymphocytes  also  have  less  
capacity  to  multiply  to  antigenic  stimuli19,20.They  have  less  killing  
activity  and  capacity  against  microbes  and  virally  infected  cells. The  
lymphocytes  also  have  less  capacity  to  synthesize  interleukins  which  
are  important  regulatory  molecules  in  immunity. The  preterm  
newborns  T cell  mediated  immune  responses  like  helper T cell  
induced  B-cell  stimulation  to  produce  antibodies, Cytotoxic  T-cell  
mediated  killing, and  recognition   of  T-cell  dependent  proteins and 
immunogens  is  impaired19,20.Preterms  may  also  have  defective B-cell  
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mediated  immune  responses  according  to  a  recent  study  but  others  






The  full  repertoire  of  antigen  recognizing  cell  receptor  on  the  
B-cell  lines  is  acquired  only  after  birth  and  after  37  weeks  
gestation. The  preterm infant  does  not  have  sufficiently  enough  B-
cell  receptors  to  identify  the  diverse  array  of  microbes  in  its  
environment  to  which  it  is  exposed  prematurely20,21.The  capacity  to  
produce  immunoglobulin  across  all  classes  is  reduced .IgM is only 
produced in significant quantity. In  addition  to  these  intrinsic  defects  
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the  placenta  acts  as  an  efficient  filter early  in  gestation  and  the 
crossing  of  class of  IgG  molecules  in  to  the  fetal  circulation  is  
impaired20,21.There  is  a  positive  correlation  between  gestational  age  
and  antibody  levels  derived  from the  mother. 
BCG vaccine and Nonspecific immunity 
 
BCG vaccine  is one of the oldest vaccines in use in developing 
countries. It has about  40-50%  efficacy  in  preventing  the  adult  form  
of  tuberculosis  according  to  a  Meta-Analysis ( Timothy Brewer 
2000).At the inception of this vaccine it had been observed that it also 
reduced infant mortality non specifically. Many  studies  in  America  and  
England in the 1950s27,28showed  mortality  in  childhood in  general  
reduced  by  25%  with  a  confidence  interval  of (0.58-0.92).  A 
retrospective  Brazilian  study  in  1992 showed  that BCG  reduced lower  
respiratory  tract  infection  related  death  by  half (Niobey et al)31 .This  
study rejuvenated  interest  in this  age  old  vaccine  in  the  developed  
nations  also .Two  randomized  controlled  trials  in  Western  Africa  
indicated  that  BCG  improved  survival  in  the  low  birth  weight infant 
in  the  newborn period nonspecifically. The mechanism of action 
remained a puzzle till recently. 
It is believed widely that  innate  immune  responses  is  
unchanging. Now  evidences have emerged  to  the  contrary  which  
question  this  age  old  dogma. Innon-human  species  like  mice  and 
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invertebrate  animals  and  in  plants innate  immunity  has  known  to  
have  adaptive  characteristics34,35.Though  this  form  of  immunity,  also  
known as Trained  immunity24,25,  was  long  known to  exist in  other  
species, evidence  for  its  presence  in  humans  is  
accumulatingnow.BCG, Freund  adjuvant  and  Muramyldipeptide  are  
some  of  the  important  substances  which  have  been shown  to  elicit  
this  response  in lab  experiments24,25.The  mechanism  of  action  of  
BCG  seems  to  be  through  trained  immunity. 
In a  recent  study (Kleinnijenhueis et al)BCG  was   administered  
to a   sample  adult  population and Tumor  necrosis  factor,Interleukin1 
and  gamma  interferon were studied in this population32. They found an 
increase of the above mentioned factors against non-specific  antigens  
unrelated  to  mycobacteria. This  effect  lasted  for  greater  than  ninety  
days. here  was  increased  levels  of  CD 11  and  TLR  on  the  surface  
of  macrophages32.It  was  elucidated  that  epigenetic33 mechanism  like  
DNA associated Histone  protein  methylation was  involved. Pattern 
recognition molecule NOD was  also  involved  in  this  effect. Another  
study  by same investigator  was  done  in  T  cell  and  Bcell  immune 
deficient  mice. In  this  study  BCG  protected  mice  from  death  due  to  
Candida  infection. Mice in control  limb  died  due  to  disseminated  
candidiasis25,26.It  was  found  that  epigenetic  mechanisms  like  DNA  
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associated  protein  methylation  and pattern  recognition  molecule  NOD  
was  involved  in  this  effect. 
 
The epigenetic mechanism of action of BCG 
 
The chromosomes of humans  contains  Histone proteins. 
Modification  and  alteration  of  this  DNA  associated  protein  by  
transfer  of  methyl  and  acetyl  group  carbon moieties  causes  increased  
DNA  synthesis  of  inflammatory chemokines and  immune regulatory  
cytokines. The specified  group, especially  the  methyl   group, is added  
to  the  fourth  lysine carbon  atom in  the  histone  3 protein following  
BCG administration  and this  acts  as  an  epigenetic  
mechanism33.Epigenetic  mechanism  can  be  defined  as  modification of  
genes  by  indirect  mechanisms  rather  than  by  direct  action  on  
promoters  flanking  the  gene  of  interest. This  theory  was  confirmed  
when  it  was  found  that  histone  methylationof  DNA  was  high  in  the  
region  of  Toll  like  receptor (TLR)  4  DNA  area  of  macrophages  
after  administration  of  BCG  in  volunteers32.TLR  are  pattern  
recognizing  molecules  on  the  cell  surface  which  play  an  important  
role  in  non-specific  immunity to  bacteria.The  effect  lasted  till three  
months  after  BCG  vaccine. 
The nucleotide binding oligomer 2 domain receptor(NOD2)  
mediates the  enhancement in innate immune response  following  BCG  
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vaccination. Receptor interacting serine /threonine  protein  kinase 2 (RIP 
Kinase 2) has  also  been  found  to  play a role  in  the  BCG  mediated  
effect32.To  find  the  exact  mechanism  of  action  of  BCG  a  study  was  
conducted on monocytes  in  vivo  in  cell  culture. It  was  found  that  
NOD 2  agonist  called  the  MDP  protein  caused  elevation  in  
synthesis  of  various immune modulatory cytokines  and  
tumornecrosisfactorafter  second  antigenic  exposure. The  TLR  ligand  
and  agonists  like  lipopolysaccharide  and  dead  microbes  did not  have  
any  effect  on  this  immune response. This  indicates  that  NOD  
mediates  the  effect of  Bacillus  calmette guerine  on  increase  in  innate  
immune  response32.RIP Kinase 2 blockers  diminished  this  trained  
immune  response  and  so  this  compound  may  also  be  involved  in  
the  enhancement  by  BCG  of  trained  immune  response. Interference  
with  binding  of  methyl  group  to  DNA  associated  protein  Histone  
by  enzyme  inhibitors  blocked  immune  enhancing  function  of  BCG. 
Thus increased trimethylation of histone H3 at lysine 4 (H3K4) is 
the mechanism of action through which  BCG enhances non- specific 
immunity.NOD2 and RIP Kinase 2 act as mediators of this action32. 
 
In confirmation of this hypothesis, H3K4 trimethylation was found 
to be significantly elevated at the level of cytokine and TLR4 promoters 
in the circulating  monocytes collected   more  than 3 months after 
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Classical adaptive immunity & Th2 responses to non-specific 
antigens after BCG 
A longitudinal study of BCG Vaccination in Early Childhood was 
done to assess the effect on Innate and  Adaptive immune responses34,35 
for both specific & non specific  antigens by   YennyDjuardi et 
al.36They noted that   there was some increase in   polyclonal responses  
to  unrelated   antigens  as assessed by Interferon-gamma and   interleukin 
5  production when stimulated by PHA (Phytohemaglutininin). The 
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correlation coefficients between responses to PHA and  PPD  (purified   
protein   derivative) were strongest at 5 months and one year of Age36. 
This suggests that BCG can have an effect on cellular immunity to non-
mycobacterial antigens also. 
 
In this cohort study the cytokine profiles following BCG 
vaccination was assessed. Immune response to PPD was assessed before 
vaccination and at 5 months, 1 year, and 2 years, followed by BCG scar 
measurement at 4 years. 
 
BCG   induced both Th1 and Th2 type responses against PPD at 5 
months of age. While Th1 response was sustained, Th2 responses showed 
a decline over time. BCG scar size strongly correlated with Th2 responses 
to PPD at 5 months of age. It was also observed that there were no 
conclusive effects of BCG vaccination on the innate immune responses 
and no significant   increase in IL10or TNF levels. There was a small 
increase in general adaptive immune responses to PHA36. 
 
Summary of BCG action mechanism’s in enhancing immunity 
 
BCG  enhances  immune  response  to unrelated  non  
mycobacterial  antigens  in  a  number  of  ways. 
1) Specific and non-specific  immunity  modification. 
2) Th2 responses and classic  Th1response. 
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3) Genetic reprogramming  by  epigenetic  mechanisms  affecting  
innate  immunity. 
Usually  adaptive  immune  response which  is  mediated  by 
thymic  lymphocytes  takes  time  to  be  fully  functional  following  
heterologous  antigen  exposure. The trained  innate  immune   responses  
in  contrast  takes  effect  quickly within  three  days  of  BCG  
administration  according  to  some  studies (Peter aby et al). 
 
A  Randomized trial in Guinea Bissau by PeterAby and Adam 
Roth et al37 tested the effect of BCG vaccine in  Low Birth Weight 
infants as  a  part  of a larger  study  to  assess the effect  on  infant  
mortality  in   study   subjects. The study showed that Neonatal mortality 
ratio was RR 0.52(.33-.82) when BCG was given compared to the control 
group. There was almost 50% reduction in Neonatal mortality. In this 
trial the beneficial effect of  vaccination  occurred  within 3 days of 
intervention37. 9 deaths occurred in the BCG group and 21 deaths in 
control group. The death Rate fall was due to the reduction in neonatal 
sepsis and respiratory infections. 
 
The authors concluded that BCG vaccination in low birth weight 
group was safe. Another study was conducted in Low Birth Weight 
infants by Biering Sorensenet al. It was a randomized trial   involving 
Low-birth-weight children who received BCG vaccination at first health 
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center visit38.A total of 105 low -birth-weight children coming for first 
vaccination were recruited. The mortality rate ratio for BCG was 0.17 
(95% CI = 0.02-1.35) within 3 days of vaccination,0.28 (0.06-1.37)till 
1month  age, and 0.27 (0.07-0.98) after 2 months of age. The mortality 
rate ratio was 0.41 (0.14-1.18) (P = 0.098) in infancy. The study 
concluded that administration of BCG vaccine at first contact may have 
contributed to the lower mortality in the study population. 
 
Maria-Graciela Hollm–Delgadet al did a study to determine whether 
BCG vaccination led to a reduction in risk of acute lower respiratory 
infection (ALRI) among  5year old children39. It was a retrospective 
cohort study wherein data was collected from Macro International 
Demographic and Health Survey and United Nations Children’s Fund 
Multiple Indicator Cluster Survey. A primary cohort of 58021 children 
from 19 countries (2005–2010) and a secondary cohort of 93301 children 
in 18 countries (2000–2007) were analyzed. Standardized questionnaires 
were used during home visits to collect data. Vaccination site was 
inspected and measurement of general health indicators was made. BCG 
vaccination was associated with a17% to 37% reduction in risk of 
suspected AL RIinbothcohorts. Children vaccinated with BCG had a 
significantly lower risk of suspected ALRI according  to  the  authors , 
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but  they  were  not  sure whether  reduction  in underlying  risk  of  
Tuberculosis  could  have  contributed  to  this  effect. 
 
BCG vaccination  reduction  in  the   development of allergic 
disease in children  was studied in  a randomized, prospective, single-
blind study by Steenhuis TJetal and concluded  that there  may  be a 
small  beneficial effect of BCG and   a   trend towards less eczema and   
there  was  statistically significant less use  of  allergic medication  in  
eczema  patients  which  may be    due  to  immune modulatory  effects of 
BCG vaccine. 
Elizabeth j Anderson et al studied whether strain of BCG vaccine 
had an influence  on specific and non-specific immunity40.  In  Uganda, 
The influence of BCG vaccine strain on mycobacteria-specific and non-
specific immune responses in a prospective cohort of infants in Uganda 
infants from this study were administered  three strains  of  BCG  vaccine 
– Danish, Russian and  Bulgarian. It was  found  that  different  strains  
elicited  different  immune  responses  both  for  tuberculous and  non 
tuberculous antigens. Danish  strain  was the most  immunogenic  of  the  
lot  and  elicited  good  immune  response  to  specific  and  non-specific 
antigens. Adverse  reactions  were  also  more  in the  Danish  strain  
group  compared  to  others. Ninety  two  percent  in  the  Danish  group  
developed  scar  at  vaccine  inoculation  site. The  Russian  strain  was  
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least  immunogenic  and  least  adverse  effects  and  scar  formation  
occurred  in  this  group. 
The safety and immunogenicity in  Preterm newborn infant 
Studies byThayil Sudhin et al and Senghatian et al  have established 
the safety of BCG in preterm babies up to 26 weeks. In the Thayil 
Sudhan et al study42, sixty two preterm babies born below 37 weeks of 
gestation were randomly assigned to two groups. Babies in group 1 were 
vaccinated early at 34–35 weeks and  group 2  were vaccinated late at38–
40 weeks of post -conceptional age. The two groups were similar in terms 
of mean birth weight (1583 and 1546 gms), gestational age, neonatal 
medical problems, socio economic status and postnatal weight accretion. 
The cell mediated immunity to BCG was analyzed using the Mantoux test 
and thelymphocyte migration inhibition test 6–8 weeks after vaccination. 
In duration and swelling greater  than  5 mm after the Mantoux test was 
taken as adequate response. There was no significant difference in the 
tuberculin conversion rates between both Groups(80% v/s 80.7%, 
respectively).The positive LMIT between groups also was 86.6% and 
90.3%, respectively and was statistically insignificant. BCG scarring was  
similar  in  both  groups  (90.0% and 87.1%, respectively). 
 
Another study on tuberculin response in preterm infants after BCG 
vaccination at birth by M R Sedaghatian, K Kardouni et al also showed  
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similar  findings in terms of safety. But, the immunogenicity of BCG was 
less than preterm infants43. A total number of101 preterm infants between 
26 and 37 weeks gestation received BCG vaccine at birth .They were 
evaluated  at  two and four months after  BCG  vaccination. 32% of these 
infants had no visible BCG scar.  The infants were then administered 
tuberculin purified protein derivative (PPD). The test was negative in 22 
(31%) and there was an in duration of 5 mm  or  less  in another 26 (37%) 
of the infants. Scarring  and  positive  mantoux  test  was  higher  in  term  
infants  (p<0.001).Of22 infants with no BCG scar, 19 (86%) had an in 
duration of less or equal to 5mm. In infants with a positive BCG scar a 
significantly higher number had an in duration of PPD >5 mm. There 
were no significant differences between the rate of scarring and positive 
mantoux test   between   gestational age and  newborn infants born before 
or after 32 weeks' gestation. The  author  states  that routine BCG 
vaccination at birth in  preterm infants is not indicated  and   a much 
larger study has   to  be  performed.(30) 
The current IAPCOI guidelines support BCG vaccine earlier in 
Low birth weight infants after  they  are  clinically  stable. 
 
Thus  safety  of  vaccine  is  well  established  in  preterms42,43 
though  the immune genicity i.e. specific  for  mycobacteria has  been  
questioned  in  babies receiving early BCG. But nonspecific immunity 
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has not been studied much in babies  receiving  early  BCG. The strain 
specific study in Uganda and study by ThayilSudhan et al indicate it  
may not  be affected  by  prematurity and  is unrelated to scarring. This 
seems to  have  immunological  basis  also as  study by Kleinhaujes et al  
propose  adaptive  features  of  innate immunity32  for  this  effect 
mediated by Histone trimethylation (an epigenetic33 mechanism). This 
immune response unlike classical  immunity  takes  very  less time to  
take  effect .This short response  time  is  supported  by  the trial  
conducted  in Western Africa37,38. The effects were observed  within  3  
days  of vaccination . Finally  sepsis  in preterm low  birth  weight  
infants is most  lethal in the initial  1st few days of life .Therefore  early 
BCG if it really works is an attractive novel therapy against this 
background. A significant reduction in Low Birth Weight Infant mortality 
with a low cost intervention, which has epidemiological, basic science 
research and clinical evidence backing  needs to be explored, which this 








JUSTIFICATION OF STUDY 
Though  advances  in  various  aspects  of  neonatal  care  of  
preterm  infants  have tended to  improve  outcomes,  neonatal  sepsis  
continues to be a major killer disease.  Nosocomial and late onset sepsisis 
a leading cause of mortality. Costly measures like IVIG and GM-CSF 
have not shown much promise. Against this background BCG vaccine 
has been shown to haven on-specific immunological effects. Recently 
2RCT’S had shown it reduced mortality in low birth weight neonates. 
Though Indian Academy of Pediatrics Committee on Immunization 
recommends BCG in low birth weight infants as soon as they are 
medically stable, most of the babies less than 2000 gm  do  not receive  it 
during hospitalization, when they are most vulnerable. Therefore there is 
a need for studying the non –specific effects of BCG in LBW newborn 
Indian population .Moreover insight about the timing of administration 











Early BCG vaccination in low  birth  weight  newborns  less than 
2000 grams  soon after birth is  useful  in  reducing  mortality  during  
hospitalization  due  to  its Non-specific effects and also may provide 

















AIMS AND OBJECTIVES 
 
To learn the effect of early BCG vaccination  in low  birth  weight  



















To find if there is a significant reduction in hospital mortality in 
low birth weight babies less than 2 KG given early BCG (within 48 hours 




1) To study the incidence of sepsis, both clinical & blood culture 
positive sepsis cases in the intervention group and control subjects. 













“Does  Early BCG  in Low Birth Weight Newborns Less than 2kg 
provide survival advantage in newborn period?” 
Study centers: 
Department of Neonatology, Institute of Child Health &Hospital 
for Children Egmore (out born unit) and Neonatology Unit, Institute of 
Obstetrics & Gynecology and Hospital for Women & Children (Inborn 
unit), Chennai. 
Duration of Study: 
October 2013 to March 2014 
Study Design: 
Prospective Randomized controlled trial 
Materials and Methods: 
Subjects: 
Low  birth  weight  neonates  less  than  2000 grams and  less  than  
48 hrs  old admitted  to  the  neonatal units  of  Institute  of  Child  Health  






Low  birth  weight  newborns  less  than  2000 grams  admitted  in  
the  neonatal  unit and less  than  48 hours  of  age. 
Exclusion criteria: 
1) Infants with major anomalies (CDH,TEF, Duct dependent CHD, 
Intestinal obstruction, Major skeletal dysplasia). 
2) Very sick neonates (perfusion defect in spite of ionotropes, 
respiratory failure and DIVC at time of recruitment). 
3) Babies born to Hepatitis B positive mother (immunoglobulin 
would be given to child) and HIV positive mothers. 
4) Denial of consent 
Sample Size: 
The baseline  mortality from  previous  year  2013 was around 33%  
for the  population  which  we  intended  to  study. A sample   size of 277 
in  each  limb  was  arrived  at  for  an  effect  size  of  30%  reduction 
(based  on the  West  African  study) for  an  alpha  error  of  .05  and  a  
power  of  80%.The total sample size was 554. 
Randomization: 
Computed   generated random numbers generated for 6 stratified 





The stratified weight based groups were; 
1) less than 1000gms 
2)1000-1499gms 
3)1500-1999gms 
Each  group was divided  in  to  male  and  female  to  ensure  equal  
distribution  among  sex  and  weight  categories  in  the  intervention  and 
control limbs. 
The intervention 
Each  day  eligible  babies  in  both  inborn  and  out born units  
were identified and recorded  on a register. The babies who fulfilled the 
inclusion criteria were enrolled after obtaining the necessary consent 
from any one of the parents. The babies who had the exclusion criteria 
were excluded. 
The babies were randomized to intervention or control limb by 
opening opaque sealed envelopes with the respective weight and sex 
strata printed on the sides of the envelope.6 packets of envelopes for each 
stratification category were used. 
A ten Dose vial of BCG vaccine (Serum Institute India) was 
reconstituted and intradermal BCG vaccination was given to the 
intervention group in the left shoulder  region  at deltoid  insertion. 
0.05ml of vaccine was given using 26 gauge attached needle insulin 
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syringe. A wheal of 6mm-8mm was produced in all vaccinated children. 
These babies were monitored for any acute reactions. 
Controls received no BCG till discharge. 
Data Collection: 
The data was filled in individual case forms. A separate diary was 
maintained for 29th day follow up enquiry. The mothers were given a 
printed card on which the study number and vaccine details were 
mentioned to avoid revaccination and to facilitate follow-up. Telephone 
tracking was done to check the well-being of the babies. Death or 
discharge from Hospital was the primary end point. Live status on 29th 
day of life was these secondary end point. The collection of necessary 
information regarding secondary outcomes completed the case recording 
.The information was transferred to a validated excel spreadsheet. 
Statistical Analysis: 
All  statistical  analysis  was  performed  according  to  intention  to  
treat  principle.  SPSS software version 18 for Windows was used in 
analysis, standard statistical tests were employed. Categorical variables 
were analyzed using chi square test. Continuous variables were analyzed 
using student t test. Statistical significance was considered at a p value of 








A total of 511 babies were recruited into the study as against the 
calculated sample size of 554. The total admission of eligible babies 
during the period was less than expected. 252 babies were randomized to 
intervention group and 259 to control group. 
252 babies received BCG. 
138 male babies and 136 female babies received BCG. 136 male 




Table : 1 Gestational age distribution 
 
Gestational  age  
(weeks) 
BCG(252) Control(259) P value 
Less than 28 9(3.6) 16(6.2) 0.103 
28-30 41(16.3) 40(15.4) 0.103 
31-33 81(32.1) 62(23.9) 0.103 
34-36 100(39.7) 107(41.3) 0.103 
≥37 21(8.3) 34(13.1) 0.103 
 
 
Most of the babies included in the study were in the gestational age 
group of 34-36 weeks (40.5%). Only 4.9% of the study population was 
less than 28 weeks of gestational age. The distribution of babies in the 












































BCG Control P value 
<1000 21(8.3) 26(10) 0.750 
1000-1499 61(24.2) 65(25.1) 0.750 





Nearly 66% of the babies had birth weights in the 1500-1999 g 
range. Extremely low birth weight babies accounted for 9.2% of the study 
population. Comparable distribution was observed in various categories 
































Table : 3 Baseline Maternal Characteristics 
 
 
Characteristic BCG Control P value 
Maternal  age (yrs) 24.2 ± 2.1 23.6 ± 2.4 0.167 
Primi 152(60.3) 156(60.2) 0.654 
 






Seizure  disorder 
 







































Maternal factors like age, parity, anemia, hypertension, heart 




Table : 4 Perinatal factors 
Characteristics BCG CONTROL P value 
Risk of EOS (%) 148(58.7) 150(57.9) 0.923 
PROM>24 hours (%) 13(5.2) 21(8.1) 0.097 
Multiple gestation (%) 58(23.0) 59(22.8) 0.198 




112(44.4)                     
133(52.8) 
7(2.8) 




AN  steroids 







Meconium stained  
liquor 
16(6.3) 11(4.2) 0.387 

























Mean Gestation age 
(week) 
32.98± 2.6 33.10± 2.7 0.670 
Mean birth wt (grams) 1591.55±334 1570.56± 359 0.495 
Mean Age recruitment hr 10.39 ±5.26 10.31±6.06 0.874 
Male      (%) 138(54.8) 136(52.5) 0.673 
Inborn   (%) 203(80.6) 196(75.7) 0.220 
 
The important base line characteristics like mean gestational age, 
mean birth weight, mean age  of  recruitment and gender distribution 




Table : 6 Neonatal morbidity Data 
 
Characteristic BCG Control P value 
RDS 58(23) 53(20.5) 0.544 
TTN 87(34.5) 88(34.1) 0.454 
Preterm/ IUGR 56(22.2) 51(19.6) 0.671 
Term /IUGR 21(8.3) 34(13.1) 0.103 
Hypoglycemia 18(7.10) 19(7.4) 0.609 
 
Neonatal   morbidity on admission evenly distributed.  Term / 
IUGR accounted for 10.7% of the study population. 
 






















Table : 7 Treatment   Related   Factors 
 








Surfactant 47(18.7) 39(15.1) 0.334 
Invasive 
Ventilation 
67(27.6) 63(24.3) 0.699 
CPAP 92(36.7) 75(29.0) 0.079 
I.V fluids 134(53.2) 137(52.9) 0.330 
Antibiotics 139 (55.2) 148 (57.1) 0.296 














FFP 36(14.3) 34(13.1) 0.801 
Ionotropes 80(31.7) 77(29.7) 0.691 
 








Table : 8 Primary Outcome 
 
Characteristic BCG Control P value 
Death  in  hospital 53(21) 66(25.5) 0.278 
Discharge 199(79) 193(74.5) 0.278 
 
25% in the control group and 21% in the BCG group succumbed in 
hospital before discharge. Though the percentage was less in BCG group, 




Table : 9 Primary outcome inferential statistics 
 







53(21) 66(25.5) 0.78 0.52-1.18 0.278 
 
Though the odds ratio appears to favor BCG group, the wide 
confidence interval (0.52-1.18) with  the range of value extending beyond  





Table : 10 Secondary outcome Incidence of Sepsis 
Characteristic BCG Control P value 
Culture  positive 
sepsis 
12(4.8) 18(6.9) 0.143 
Screen positive 61(24.2) 46(17.8) 0.143 
 
The babies were monitored for occurrence of sepsis during their 
hospital stay. 73 neonates in BCG group and 64 neonates in control group 
underwent septic workup when they developed clinical features 
suggestive of sepsis. 12 babies in the BCG group and 18 babies in the 
control group had culture proven sepsis. Nearly 24% in BCG group and 
18% in control group were screen positive but culture negative. Though 
statistically insignificant, culture positive sepsis was less in BCG group 






Characteristic BCG Control P value 
29th Day tracking 120 102 0.08 
Post dischargedeath 
( up to  28  days) 
4 3 0.826 
Survived  till  28  




On 29th day follow-up 120 babies in BCG group and 102 babies in 
control group were tracked. 4 babies in the intervention group and 3 
babies in the control group died post discharge. 79 in the BCG group and 
91 in the control group could not be tracked in spite of earnest efforts. 
The lost for follow-up percentage was 33%, but this was at secondary end 
point. There was no significant difference in post discharge mortality 






Organism BCG Control P value 
E.coli 9(3.6) 12(4.6) 0.735 
Klebsiella 2(.8) 4(1.5) 0.735 
Staph.aureus 1(.4) 1(.4) 0.735 
Pseudomonas 0 1(.4) 0.735 
 
The organisms isolated in culture positive cases were E.coli, 
Klebsiella, Staph aureus and Pseudomonas. E.coli was the dominant 
isolate in both the groups. There was no significant difference in the type 
of organisms grown in culture between groups. 
 
Table : 13 Duration  of  hospitalization 
Characteristic BCG Control P  value 
Hospitalization   
days 
7.12 ± 6.8 6.42 ± 7.3 0.272 
 
The   mean duration of hospitalization was similar in both groups -




The   survival  function  shows  a  small  favorable  benefit  of  





Chi-Square df Sig. 
Tarone-Ware 3.640 1 .056 




Table : 14 Sepsis related mortality 
 
Sepsis BCG (n=73) Control(n=64) P value 
Death 32(43.8) 36(56.2) 0.201 
Discharge 41(56.2) 28(43.8) 0.201 
 










This single center study to analyze the non- specific   
immunological effects of BCG    in reduction of in hospital mortality in 
low birth weight neonates, the  incidence  of  sepsis  and  provision of  
survival  advantage  in  the newborn period  is first of  this  kind  to be 
conducted  in  India. 
 The present study came up with the following results; The  trial  
shows  a  slight  reduction  in  Hospital mortality  in the  BCG group 21% 
as against  25.5% in the  control  group. But it is not statistically 
significant. The secondary outcomes like sepsis and mortality in neonatal 
period showed no significant difference. In fact 29% of neonates had 
sepsisin BCG group against 24.7% in controls. Sepsis  related  mortality  
was  also not significantly different in both the groups though it was less ( 
43.8% ) in BCG group  compared  to ( 56.2% ) control  group . The mean 
duration of hospitalization was 7.12 days in BCG group. It was 
marginally longer than control group (6.42 days) but was not significant.  
The West African study by Peter Aby et al had evaluated Infant 
Mortality in two groups (Early BCG and Routine practice) which was 
their primary outcome. They failed to show a significant result. Though 
there was 17% reduction in infant mortality in early BCG it did not reach 
significance. (IMR in early BCG 10.2% and control 12.4%) A general 
reduction in infant mortality in general population was cited as one of the 
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reasons for the negative result. In secondary analysis, neonatal mortality 
ratio was studied and they found a significant relative risk reduction of 
48% in neonates.  
The other similar study by Beiring Sorensen et al Bandimin 
Guinea-Bissau,38is discussed. A Total of 105 LBW (<2500 gm) coming 
for first vaccination were randomized to receive bacillus BCG 
immediately or later. (Current practice)The Mortality RR for BCG was 
0.17 (CI = 0.02-1.35) within 3 days of enrollment, 0.28 (0.06-1.37) in the 
1st month, and 0.27 (0.07-0.98) after 2 months of age. The Mortality RR 
reduced to 0.41 (0.14-1.18) (P = 0.098) in infancy. The study population 
was neonates less than 2500 gm compared to ours where we included 
babies weighing less than 2000 gm. Their study population was recruited 
from out patients while we recruited only inpatients. Though there was a 
reduction in mortality to an extent of 72% in their study the confidence 
intervals were wide making it statistically insignificant. Sepsis was the 
leading cause of mortality in both African studies which is also the major 
determinant of mortality in our study. The strains used in the Beiring 
Sorensen et al study was also Danish.  
The possible reasons for failing to detect a significant reduction in 
mortality; There is a beneficial effect but it is less than the expected effect 
size which this study was designed to detect. The explanations for the 
lack of beneficial effect might be the following. 
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 a) The strain used in this study was the Russian  which  may  be 
weakly immunogenic  and  may not elicit  the non -specific  
beneficial effect of BCG in study  population. 
b) The young preterm infants may not have sufficient immune 
response to the BCG vaccine in comparison to older neonates 
c) The ethnicity and genetics of the study population.  
BCG strain 
The West African study by Peter Aby et al used the Danish strain 
of vaccine and their  study  showed a relative risk reduction 0.55(0.34-
0.89). The Russian strain has been found to be less immunogenic in a 
study from Uganda. In that Study  by  Elizabeth J Anderson et al40 
Infants were  administered three  different  strains  of  BCG -  Danish 
1331, Russian  and  Bulgarian. Immune  regulatory  molecule  levels  
were  assessed   after  a  period  of  one  year to both  specific  and  non - 
specific  antigens. The  strains  differed  in  their  immunogenicity 
significantly. Scar formation and adverse effects were significantly 
different among the strains.  BCG  of  Danish  strain  was  most  
immunogenic. The  Russian  strain  was  found  to  be  least  




Prematurity and poor immune response to vaccine 
The  second  reason  could  be  the  poor immunogenicity  of  the  
BCG  vaccine  in  preterm  Babies. he study  by Senghatian et al  shows 
significant  reduction  in  immunogenicity assessed  by scar, BCG  nodule  
and  Mantoux reactivity  between  term  and  preterm  neonates43. 
Adverse  events  and  scar  frequency  was  significantly  less  in  this  
group .Some studies suggest that specific immune responses of preterm 
neonates to BCG vaccine may be impaired. The  lack of sufficient  non- 
specific immune response in preterm population  itself   could be one of 
the reasons for the negative result in the present study. But ThayilSudhin  
et al  have found  the  vaccine to  be equally  immunogenic  in  preterm 
babies based  on  Mantoux , LMIT and  BCG  scar.42 
The third reason could be the ethnicity and genetics of the study 
population. There is no study comparing non-specific effects of BCG in 
various races. Studies on the specific immune response of BCG indicate it 
varies with the ethnicity and geography. The most controversial aspect of 
BCG is the variable efficacy found in different clinical trials, which 
appears to depend on geography. Trials conducted in the UK have 
consistently shown a protective effect of 60 to 80%, but those conducted 
elsewhere have shown only 50% Protective effect, and efficacy appears 
to fall the closer one gets to the equator. BCG was shown to have no 
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protective efficacy against pulmonary tuberculosis in the ICMR study in 
the South Indian population. 
A 1994 systematic review found that the BCG reduces the risk of 
getting TB by 50% (Timothy et al). The differences in effectiveness, 
depends on several factors such as genetic differences in the populations, 
changes in environment and exposure to other bacterial infections. 
Though, molecular study in adults byJohannekeKleinnijenhuisa 
et al showed that BCG vaccination in Healthy adult volunteers led to a 
four- to seven fold increase in the production of Interferon gamma and to 
a twofold enhanced release of monocyte derived cytokines, such as TNF 
andIL-1β, in response to unrelated bacterial and fungal pathogens. 
Molecular studies in newborns and children to asses this Non-specific 
immunity have not been done so far. 
The possibility of inadequate sample size 
The effect size of 30% might be too optimistic and a larger sample 
size may be required.  The baseline mortality for the intended study group 
in 2012 year was around 33%. The  extra mural  unit  had  a  higher  
mortality though  the  number  of  admissions  in the  select  category  
was  1/3rd  of  the  total  study  population  of  interest. As  there  were  no 
previous  such  studies  in  India  and  the  West African  studies  had  
shown  almost 50% reduction  in  mortality a conservative 30% effect 
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size was chosen to Calculate the sample size. It  was  also  assumed  that  
2/3rd  of  cases  would  be  recruited  from  intramural  unit  and  1/3rd  
from  extramural  unit  based  on  previous  year Data.There was a 
reduction in number of cases from the out-born unit and only 19% were 
recruited from it.There was also a reduction in mortality in general 
decreasing the baseline mortality to 23.3% against the expected 33%. 
Therefore a larger sample size may be needed to detect a statistical 
difference between both groups.  
The final  reason  for  the  outcome  maybe  that  the non- specific 
effects  of  the  vaccine  may  be  too  insignificant in study population to 
benefit clinically. But  this  study  does  not  have adequate  power  to  
substantiate  that  claim. A larger trial with a smaller effect size,   larger 





Strengths   of the study. 
 
It is a Randomized Control Trial Demonstrated the feasibility of 
early administration of BCG in low birth weight neonates. Safety of early 
BCG has been established fairly well as we did not record any adverse 





Limitations of the study 
The  calculated  sample  size  of   554  in  total  could  not  
achieved  due  to  a general  decrease  in  the  number  of  admissions  
both  in  inborn  and out-born unit and 511 cases were recruited in total 
There  was  33.6%  loss  to  follow up  for  the  secondary  outcome  of  
Neonatal Mortality The  BCG  strain  used was  Russian  strain, while  
the  other  studies  in West Africa used Danish strain. This may be a 
confounding factor as the study in Uganda felt Russian strain was less 
immunogenic. Efforts were made to procure the Danish strain but could 











Early  BCG  administered   to  low  birth  neonates  less  than  2000  
grams  within  48 hours  of life did not confer any  significant  survival  
advantage  to these neonates. Early BCG did not show reduction in the 
incidence of infections in low birth weight babies. 
 Early BCG   failed to reduce mortality in the neonatal period 
significantly Further  larger  studies  are  required  to  prove  or  disprove  





Future   directions   for Research 
The   future  studies  must  target  a  smaller  effect  size  with  a  
larger  sample  size using  the  different  strains  of  BCG  vaccine  to  get  
a  definitive  answer  on  the benefit of  BCG  in  the  study  population. 
The  cytokine  profiles  may  also  be  assessed  in  future   studies  
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Place of delivery  DOB B.wt 
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Resucitation details apgar                         1mt                       5mt 
Sepsis risk score (AIIMS) 
perinatal h/o                        
Reason for referral(out born) 
Mode of transport 
Support on arrival 
Condition on arrival                              temp                               vitals                                      




Anthropometry HC CC length                          
wt  
NBS score                                       ga 
Admitting diagnosis       admission   wt 
DOA                                          time                                       age at adm 
Admitting hospital  
Hemodynamic stability 
Major malformation 
HIV/HepB status mother 
BCG group assigned             early                    age in hrs 
control 
Course  during  hospitalization 
Final  diagnosis 
Primary outcome 
Secondary outcome(sepsis) 
29th day outcome 
Hospital management details                    
Surfactant 
Ventilation 



















AN steroidAntenatal steroids 
BCG Bacillus CalmetteGuerine 
IAPCOI IndianAcademy of Pediatrics Committee on 
Immunization 
EOS Early Onset Sepsis 
LOS Late Onset Sepsis 
TLR Toll Like Receptor 
IFN Interferron 
CD Cluster of  Differentiation 
Th1 Thymic Helper Cell type 1 response 
B cell B Lymphocyte 
NOD2 Nucleotide binding oligomer 2 domain receptor 
RIP kinase 2 Receptor interacting serine  protein  kinase  
H3K4 Histone  H3 at lysine 4 
NK cell Natural Killer Cell 
PHA Phytohemaglutinin 
IL-10 Interleukin-10 
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5 5 8 1 1 0 1 1 1 3 2 1 3 2 2 2 2 1 4 3 4 1 5 2 9 2 1 1 3 2 1 1 1 2 
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0 5 8 1 2 1 1 2 1 2 2 1 3 1 2 2 1 1 3 2 1 1 5 3 2 2 1 1 3 2 1 5 1 2 
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0 5 8 1 2 6 2 1 1 1 1 2 3 1 1 1 1 1 3 1 2 1 5 1 9 2 3 1 3 2 2 4 1 3 
1




















































0 5 8 1 3 0 1 1 2 3 2 1 3 1 2 2 2 1 3 3 4 2 5 6 9 2 1 1 3 2 1 2 1 3 
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0 5 8 1 3 6 2 1 1 1 1 2 3 1 1 1 1 1 3 1 2 1 5 1 2 2 3 1 3 2 1 1 1 2 
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5 5 8 4 1 2 1 1 2 2 2 1 3 1 2 2 1 1 4 3 1 2 5 2 5 2 1 1 3 2 1 2 1 2 
1


















0 5 1 1 1 2 1 1 1 2 2 1 3 1 2 2 1 1 4 2 1 2 5 6 2 2 1 1 3 2 1 5 1 2 
2






































0 1 8 1 3 0 1 1 1 3 2 2 3 2 2 2 2 1 2 3 4 1 5 9 5 2 1 1 3 2 2 5 1 3 
1





















0 1 8 1 3 0 1 1 1 3 2 2 3 2 2 2 1 1 2 3 4 1 5 6 9 2 1 1 3 2 2 5 1 3 
1



















0 5 6 1 3 4 2 1 1 1 1 2 3 1 1 1 1 1 4 1 2 3 1 2 8 2 3 1 3 2 1 2 1 2 
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2


























































































































0 5 8 1 3 3 1 1 1 2 2 1 3 1 2 2 1 1 3 2 4 2 5 3 2 2 1 1 3 2 2 2 1 2 
1
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1
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0 5 8 3 2 6 3 2 1 1 1 2 3 1 1 1 1 1 5 1 3 3 1 2 8 2 4 3 3 2 1 1 2 1 
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0 5 8 1 2 5 2 1 1 1 1 2 3 1 1 1 1 1 4 1 2 2 5 1 9 2 2 1 3 2 1 5 1 3 
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